Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial.

Dabbous HM, El-Sayed MH, El Assal G, Elghazaly H, Ebeid FFS, Sherief AF, Elgaafary M, Fawzy E, Hassany SM, Riad AR, TagelDin MA

Open source

DOI: 10.1038/s41598-021-85227-0
Published: 2021 Mar 31
Container: Scientific reports
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41598-021-85227-0,
  title = {Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial.},
  author = {Dabbous HM and El-Sayed MH and El Assal G and Elghazaly H and Ebeid FFS and Sherief AF and Elgaafary M and Fawzy E and Hassany SM and Riad AR and TagelDin MA},
  year = {2021},
  journal = {Scientific reports},
  doi = {10.1038/s41598-021-85227-0},
  url = {https://doi.org/10.1038/s41598-021-85227-0}
}

RIS

TY  - JOUR
TI  - Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial.
AU  - Dabbous HM
AU  - El-Sayed MH
AU  - El Assal G
AU  - Elghazaly H
AU  - Ebeid FFS
AU  - Sherief AF
AU  - Elgaafary M
AU  - Fawzy E
AU  - Hassany SM
AU  - Riad AR
AU  - TagelDin MA
PY  - 2021
JO  - Scientific reports
DO  - 10.1038/s41598-021-85227-0
UR  - https://doi.org/10.1038/s41598-021-85227-0
ER  -

APA

HM, D., MH, E., G, E. A., H, E., FFS, E., AF, S., M, E., E, F., SM, H., AR, R., & MA, T. (2021). Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial.. Scientific reports. https://doi.org/10.1038/s41598-021-85227-0

Source records

pubmed · retrieved 2026-11-10T11:33:47.924Z